Aeeris (AER) Stock Price, News & Analysis

Company Overview

AerCap is the global leader in aircraft leasing. AerCap serves approximately 200 customers in approximately 80 countries with comprehensive fleet solutions. AerCap has its headquarters in Dublin with offices in Shannon, Los Angeles, Singapore, Amsterdam, Shanghai, Abu Dhabi, Seattle and Toulouse.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$4.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AER Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Aeeris own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeeris investors own include Incyte (INCY), Heron Therapeutics (HRTX), Celldex Therapeutics (CLDX), BioMarin Pharmaceutical (BMRN), bluebird bio (BLUE), BeiGene (BGNE) and Bicycle Therapeutics (BCYC).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: Business Services
• Current Symbol: ASX:AER
• CIK: N/A
• Web: www.aeeris.com
• Phone: 61 2 6674 2711
• Fax: N/A
• Employees: 740
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -20.07%
• Pretax Margin: N/A
• Return on Equity: -35.31%
• Return on Assets: -15.84%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.11
• Quick Ratio: 4.66

Sales & Book Value

• Annual Sales: A$2.97 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 10.67
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 73,010,000
• Free Float: N/A
• Market Cap: A$4.39 million
• Optionable: Not Optionable
• Beta: 0.52